The Pseudomonas fluorescens secondary metabolite 2,4 diacetylphloroglucinol impairs mitochondrial function in

Olive Gleeson1, Fergal O'Gara, John P Morrissey

  • 1Department of Microbiology, University College Cork, Cork, Ireland.

Antonie Van Leeuwenhoek
|January 22, 2010
PubMed

Insights

Pseudomonas fluorescens produces 2,4-diacetylphloroglucinol (DAPG), an antifungal compound. This study reveals DAPG inhibits fungal growth by impairing mitochondrial function, leading to fungistasis and petite cell formation in yeast.

Area of Science:

  • Microbiology
  • Biochemistry
  • Mycology

Background:

  • Pseudomonas fluorescens produces antifungal compounds like 2,4-diacetylphloroglucinol (DAPG).
  • DAPG is linked to disease suppression in soils and has potential as a biocontrol agent.
  • Mechanisms of DAPG's antifungal action and fungal responses are poorly understood.

Purpose of the Study:

  • To investigate how DAPG inhibits fungal growth.
  • To understand fungal responses to DAPG exposure.
  • To elucidate the role of specific yeast proteins in DAPG tolerance.

Main Methods:

  • Utilized a yeast model system.
  • Conducted phenotypic assays and molecular genetics.
  • Employed molecular physiological probes to assess mitochondrial function.

Main Results:

  • DAPG inhibits fungal growth by impairing mitochondrial function.
  • DAPG exhibits fungistatic effects and induces petite cell formation in yeast.
  • Increased expression of Pdr5p and Snq2p is a secondary effect of mitochondrial damage, not conferring DAPG tolerance.

Conclusions:

  • DAPG's antifungal activity stems from mitochondrial dysfunction.
  • Yeast response to DAPG involves fungistasis and petite cell induction.
  • Multidrug efflux pumps are not primary mediators of DAPG tolerance.